succinobucol has been researched along with betadex in 1 studies
| Studies (succinobucol) | Trials (succinobucol) | Recent Studies (post-2010) (succinobucol) | Studies (betadex) | Trials (betadex) | Recent Studies (post-2010) (betadex) |
|---|---|---|---|---|---|
| 53 | 5 | 16 | 8,785 | 97 | 4,452 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Dan, Z; He, X; Li, Y; Shen, Q; Xu, M; Xu, Y; Yin, Q; Yu, H; Zeng, L; Zhang, P; Zhang, Z; Zhong, D; Zou, L | 1 |
1 other study(ies) available for succinobucol and betadex
| Article | Year |
|---|---|
A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer.
Topics: Animals; Antineoplastic Agents; beta-Cyclodextrins; Breast Neoplasms; Cell Movement; Disease Models, Animal; Drug Delivery Systems; Female; Hydrogen-Ion Concentration; Lung Neoplasms; Mice, Inbred BALB C; Nanostructures; Neoplasm Invasiveness; Polyethylene Glycols; Probucol; Treatment Outcome | 2016 |